🇫🇷
France · FR · FR:67695203
PEMAZYRE 13,5 mg, comprimé
ReimbursedATC L01EN02
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerINCYTE BIOSCIENCES DISTRIBUTION (PAYS-BAS)
CountryFR (France)
ATC codeL01EN02
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip133400930223710plaquette(s) (ACLAR RX) polytrifluorochloroéthylène PVC papier aluminium de 14 comprimé(s)EUR 6.45
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "67695203",
"date_amm": "2021-03-26",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1535",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}Related drugs
Other records sharing ATC code L01EN02.
- ISPemazyreIncyte Biosciences Distribution B.V.
- ISPemazyreIncyte Biosciences Distribution B.V.
- 🇨🇭Pemazyre
- PLPemazyreIncyte Biosciences Distribution B.V.
- PLPemazyreIncyte Biosciences Distribution B.V.
- PLPemazyreIncyte Biosciences Distribution B.V.
- 🇨🇭PemazyreIncyte Biosciences International Sàrl
- ISPemazyreIncyte Biosciences Distribution B.V.
Access this data programmatically
Query PEMAZYRE 13,5 mg, comprimé and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.